EUVIMEDEUVIMED entdecken
Crossref

Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies

Patricia Muschong, Liang Jin, Jan Schejbal, Mario Mezler, Manuel Weinheimer

Pharmaceutical Research · 2023

DOI: 10.1007/s11095-023-03490-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, 2023. Verfasst von Patricia Muschong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co KG, Knollstr, 67061, Ludwigshafen, Germany. Hauptthemen laut MEDLINE: Madin Darby Canine Kidney Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: In previous studies, we established and validated three Madin Darby Canine Kidney MDCKII cell lines, recombinantly modified with zinc finger nuclease (ZFN) technology. Here, we investigated the applicability of seeding these three canine P-gp deficient MDCK_ZFN cell lines, directly from frozen cryopreserved stocks without previous cultivation for efflux transporter and permeability studies. This technique is referred to as "assay-ready" and allows for highly standardized conduction of cell-based assays and shorter cultivation cycles. METHODS: To obtain a rapid fitness of the cells for that purpose, a very gentle freezing and thawing protocol was applied. Assay-ready MDCK_ZFN cells were tested in bi-directional transport studies and compared to their traditionally cultured counterparts. Long-term performance robustness, human effective intestinal permeability (Peff) predictability and batch to batch variability were assessed. RESULTS: Efflux ratios (ER) and apparent permeability (Papp) results were highly comparable between assay-ready and standard cultured cell lines with R2 values of 0.96 or higher. Papp to Peff correlations obtained from passive permeability with non-transfected cells were comparable independent of the cultivation regime. Long-term evaluation revealed robust performance of assay-ready cells and reduced data variability of reference compounds in 75% of cases compared to standard cultured MDCK_ZFN cells. CONCLUSION: Assay-ready methodology for handling MDCK_ZFN cells allows more flexibility in assay planning and reduces performance fluctuations in assays caused by cell aging. Therefore, the assay-ready principle has proven superior over conventional cultivation for MDCK_ZFN cells and is considered as a key technology to optimize processes with other cellular systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Madin Darby Canine Kidney CellsHumansAnimalsDogsWorkflowReproducibility of ResultsCaco-2 CellsBiological Transport

Stichwörter der Autor:innen

assay-readycell cultureefflux transport studiesmadin-darby canine kidney type II (MDCKII) cellspermeability

Autor:innen und Institutionen

  • Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co KG, Knollstr, 67061, Ludwigshafen, Germany.
  • Quantitative, Translational & ADME Sciences, AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA, 01605, USA.
  • Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co KG, Knollstr, 67061, Ludwigshafen, Germany. manuel.weinheimer@abbvie.com.

Zitieren

APA

Muschong, P., Jin, L., Schejbal, J., Mezler, M., & Weinheimer, M. (2023). Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies. Pharmaceutical Research. https://doi.org/10.1007/s11095-023-03490-4

Vancouver

Muschong P, Jin L, Schejbal J, Mezler M, Weinheimer M. Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies. Pharmaceutical Research. 2023. doi:10.1007/s11095-023-03490-4

BibTeX
@article{Muschong2023,
  author = {Muschong, Patricia and Jin, Liang and Schejbal, Jan and Mezler, Mario and Weinheimer, Manuel},
  title = {Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies},
  journal = {Pharmaceutical Research},
  year = {2023},
  doi = {10.1007/s11095-023-03490-4}
}
Kostenlos starten →